Management of High-Grade Squamous Intraepithelial Lesions (HSIL)

Risk Assessment and Initial Management

The American College of Obstetricians and Gynecologists recommends that women with HSIL cytology undergo an immediate loop electrosurgical excision procedure (LEEP) or colposcopy with endocervical assessment due to the high risk of significant cervical disease, with 53-66% of women having CIN 2 or greater on colposcopy and 84-97% having CIN 2 or greater when evaluated using LEEP 1, 2
Approximately 2% of women with HSIL have invasive cancer, highlighting the need for prompt evaluation and treatment 3
Due to the considerable risk of CIN 2 or greater and high prevalence of HPV DNA positivity, intermediate triage using HPV testing or cytology is inappropriate for women with HSIL, as recommended by the American College of Obstetricians and Gynecologists 3
Colposcopy can miss a significant number of CIN 2,3 lesions, which can lead to serious consequences if not detected, emphasizing the importance of careful evaluation and follow-up 2

The American College of Obstetricians and Gynecologists recommends immediate LEEP or colposcopy with endocervical assessment as first-line options for non-pregnant women with HSIL, with a preference for observation for up to 24 months using both colposcopy and cytology at 6-month intervals if colposcopy is performed and CIN 2,3 is not identified histologically 1, 3, 4
If a high-grade colposcopic lesion is identified or HSIL cytology persists for 1 year, biopsy is recommended, as outlined in the 2006 Consensus Guideline for the Management of Women with Cervical Intraepithelial Neoplasia 1, 2
If HSIL persists for 24 months without identification of CIN 2,3, a diagnostic excisional procedure is recommended, highlighting the importance of careful follow-up and evaluation 1

The American College of Obstetricians and Gynecologists recommends that adolescents and young women without a high-grade colposcopic abnormality can return to routine cytological screening after 2 consecutive "negative for intraepithelial lesion or malignancy" results 5
A diagnostic excisional procedure is recommended when colposcopy is unsatisfactory or CIN of any grade is identified on endocervical assessment, emphasizing the need for careful evaluation and treatment in this population 3

The American College of Obstetricians and Gynecologists recommends colposcopy for pregnant women with HSIL, with colposcopic evaluation conducted by clinicians experienced in evaluating colposcopic changes induced by pregnancy 2, 3
Biopsy of lesions suspicious for CIN 2,3 or cancer is preferred, while biopsy of other lesions is acceptable, highlighting the importance of careful evaluation and treatment in pregnant women 4
Endocervical curettage is unacceptable in pregnant women, and diagnostic excision is unacceptable unless invasive cancer is suspected based on the referral cytology, colposcopic appearance, or cervical biopsy 5, 3

Careful follow-up is essential as the risk for recurrence of squamous intraepithelial lesions and cervical cancer after conventional therapy is increased among HIV-infected women, as recommended by the Centers for Disease Control and Prevention 6

Failure to detect CIN 2,3 at colposcopy can lead to serious consequences due to the high risk of significant disease, emphasizing the importance of careful evaluation and follow-up 1
The rate of HSIL varies with age, with a higher rate in younger women, highlighting the need for careful evaluation and treatment in this population 3

HSIL represents only 0.5% of all cytologic samples but carries significant risk of underlying high-grade disease, according to the American Academy of Family Physicians 7
When HSIL is detected on Pap smear, the risk of histologic HSIL and cancer is approximately 69%, as stated by the National Comprehensive Cancer Network 8
For HPV-positive women with HSIL on Pap, the risk increases to 71%, as stated by the National Comprehensive Cancer Network 8
Even in HPV-negative women with HSIL on Pap, the risk remains substantial at 49%, as stated by the National Comprehensive Cancer Network 8

The risk of high-grade disease with HSIL is significantly higher than with other cytologic abnormalities, such as ASC-US, which has a 6.4-11.9% risk of CIN 2 or 3, as stated by the National Comprehensive Cancer Network 9
LSIL has a 12% risk of developing CIN 2,3 or worse within two years, according to the American Academy of Family Physicians 7
ASC-H has up to 50% risk of CIN 2,3, as stated by the American Academy of Family Physicians 10

For pregnant women with HSIL, colposcopy is recommended but treatment is generally deferred until after delivery unless invasive cancer is detected, as stated by the National Comprehensive Cancer Network 8

Underestimating the significance of HSIL - even with negative HPV testing, the risk of significant disease remains high enough to warrant colposcopy, as stated by the National Comprehensive Cancer Network 8

The National Comprehensive Cancer Network recommends immediate LEEP as an acceptable first-line therapy without prior biopsy, particularly for multiparous women not concerned about fertility 11
The American College of Obstetricians and Gynecologists suggests that biopsy showing CIN 2,3 requires treatment with LEEP, cold knife conization (CKC), cryotherapy, or laser ablation 11, 12
The National Comprehensive Cancer Network guidelines state that when colposcopy is unsatisfactory, LEEP or CKC is mandatory, and ablation is unacceptable because you cannot exclude invasive disease 11, 12
The Centers for Disease Control and Prevention recommends that HIV-infected women require careful follow-up as the risk of recurrence after treatment is significantly increased, and should be monitored with frequent cytologic screening and colposcopic examination for recurrent lesions 13

The American College of Obstetricians and Gynecologists recommends HPV DNA testing at 6-12 months as the preferred follow-up strategy, and after 2 consecutive "negative for intraepithelial lesion or malignancy" results, return to routine screening 12

The American College of Obstetricians and Gynecologists suggests that both excision and ablation are acceptable when colposcopy is satisfactory, and LEEP is the most cost-effective excisional method with a high cure rate 12
The National Comprehensive Cancer Network guidelines state that cold knife conization is preferred when microinvasion is suspected, and cryotherapy or laser ablation is acceptable for small lesions but has a lower cure rate for large lesions 11, 12